Please login to the form below

Not currently logged in
Email:
Password:

addiction

This page shows the latest addiction news and features for those working in and with pharma, biotech and healthcare.

Nektar confirms BMS deal for NKTR-214 is on track

Nektar confirms BMS deal for NKTR-214 is on track

The drug promises to deliver pain relief without the risk of addiction seen with other opioids, potentially helping to address the epidemic of opioid abuse currently gripping the US.

Latest news

More from news
Approximately 3 fully matching, plus 62 partially matching documents found.

Latest Intelligence

  • Revenue down the back of the beanbag Revenue down the back of the beanbag

    It’s become a boardroom agenda item; one where someone typically feels obliged to comment on his or her nephew’s smartphone addiction and low attention span.

  • Deal Watch January 2018

    Licence. 350. Addex Therapeutics/ Indivior. ADX71441, selective positive allosteric modulator (PAM) for addiction (pc).

  • Change in the pharma industry is inevitable Change in the pharma industry is inevitable

    profiting from the life-shortening addiction they have encouraged.

  • Pharma deals during November 2014 Pharma deals during November 2014

    Indivior will not be without its challenges as sales of its off-patent opioid addiction treatment Suboxone continue to slump.

  • Pharma deals during May 2014 Pharma deals during May 2014

    considered. A capital markets solution is emerging as a strong option.” The difficulty is that Suboxone (for treatment of drug addiction) sales are being hit by generic competition. ... It is therefore very surprising that this month Reckitt Benckiser

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics